The Efficacy and Safety of Degarelix One Month Dosing Regimens in Prostate Cancer

Completed · Phase 3

Conditions studied: Prostate Cancer

In brief

The study was a three-arm, active-control, multi-centre, parallel group study.

Key facts

Study ID
NCT00295750
Run by
Ferring Pharmaceuticals
People needed
620
Starts
2006-02-01
Expected to finish
2007-10-01
Last updated by the study team
2012-12-19

Who can join

Age: 18 and older. Sex: male. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.